Abstract
Estrogen-dependent breast cancer (EDBC) is a kind of common malignant tumor in postmenopausal women with growing tendency in recent years. Aromatase (AR) is the key enzyme responsible for estrogen biosynthesis and has been considered as an important target for designing inhibitors as potent therapeutic agents for EDBC. AR inhibitors (AIs) are divided into steroidal and nonsteroidal compounds, and the latter shows high inhibitory potency against AR. This review summarizes recent advancement in nonsteroidal AIs.
Keywords: Estrogen-dependent breast cancer, postmenopausal women, aromatase, aromatase inhibitors, nonsteroida, Nonsteroidal Aromatase Inhibitors, Aromatase (AR), therapeutic agents, nonsteroidal, peripheral tissues, endocrine therapy, multienzymatic complex, granulosa, luteal cells, glycosylated cytochrome P450, C19 androgenic, ovarian granulosa cells, prostaglandin E2 (PGE2), cellular transformation, oncogenesis, inflammatory cytokines, (EGFR) HER-2, COX-2, PGE2, CYP19, letrozole, anastrozole, tolerability, mammary tumors, long-term tamoxifen treatment, traditional Chinese medicine, flavanone, liquiritigenin, inhibitory potency, pyridinecontaining (E)-isomer, aminoglutethimide, Isoflavones, prostate cancer, imidazolic, Dual Aromatase-Sulfatase Inhibitors, Estrone 3-sulfamate (EMATE), YM511, Nimesulide Analogues, breast adipose stromal, celecoxib, Estrogen receptor
Current Medicinal Chemistry
Title: Recent Advancement in Nonsteroidal Aromatase Inhibitors for Treatment of Estrogen-Dependent Breast Cancer
Volume: 17 Issue: 30
Author(s): J. Jiao, H. Xiang and Q. Liao
Affiliation:
Keywords: Estrogen-dependent breast cancer, postmenopausal women, aromatase, aromatase inhibitors, nonsteroida, Nonsteroidal Aromatase Inhibitors, Aromatase (AR), therapeutic agents, nonsteroidal, peripheral tissues, endocrine therapy, multienzymatic complex, granulosa, luteal cells, glycosylated cytochrome P450, C19 androgenic, ovarian granulosa cells, prostaglandin E2 (PGE2), cellular transformation, oncogenesis, inflammatory cytokines, (EGFR) HER-2, COX-2, PGE2, CYP19, letrozole, anastrozole, tolerability, mammary tumors, long-term tamoxifen treatment, traditional Chinese medicine, flavanone, liquiritigenin, inhibitory potency, pyridinecontaining (E)-isomer, aminoglutethimide, Isoflavones, prostate cancer, imidazolic, Dual Aromatase-Sulfatase Inhibitors, Estrone 3-sulfamate (EMATE), YM511, Nimesulide Analogues, breast adipose stromal, celecoxib, Estrogen receptor
Abstract: Estrogen-dependent breast cancer (EDBC) is a kind of common malignant tumor in postmenopausal women with growing tendency in recent years. Aromatase (AR) is the key enzyme responsible for estrogen biosynthesis and has been considered as an important target for designing inhibitors as potent therapeutic agents for EDBC. AR inhibitors (AIs) are divided into steroidal and nonsteroidal compounds, and the latter shows high inhibitory potency against AR. This review summarizes recent advancement in nonsteroidal AIs.
Export Options
About this article
Cite this article as:
Jiao J., Xiang H. and Liao Q., Recent Advancement in Nonsteroidal Aromatase Inhibitors for Treatment of Estrogen-Dependent Breast Cancer, Current Medicinal Chemistry 2010; 17 (30) . https://dx.doi.org/10.2174/092986710792927877
DOI https://dx.doi.org/10.2174/092986710792927877 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
Call for Papers in Thematic Issues
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
Current advances in inherited cardiomyopathy
Describe in detail all novel advances in multimodality imaging related to inherited cardiomyopathy diagnosis and prognosis. Shed light to deeper phenotypic characterization. Acknowledge recent advances in genetics, genomics and precision medicineread more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Estrogen, Immunity & Autoimmune Disease
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Phosphatidylinositol 3-kinase Glu545Lys and His1047Tyr Mutations are not Associated with T2D
Current Diabetes Reviews Editorial: [Hot Topic: Imaging Inflammatory Bowel Disease: Looking Beyond the Mucosa]
Current Drug Targets The Yin and Yang of CD4+ Regulatory T Cells in Autoimmunity and Cancer
Current Medicinal Chemistry Application of Recombinant and Non-Recombinant Peptides in the Determination of Tumor Response to Cancer Therapy
Current Pharmaceutical Biotechnology The Relation Between the Chemical Structure of Flavonoids and Their Estrogen-Like Activities
Current Medicinal Chemistry In Vitro Blood-Brain Barrier Models – Latest Advances and Therapeutic Applications in a Chronological Perspective
Mini-Reviews in Medicinal Chemistry Anti-Inflammatory and Pro-Resolving Effects of N-3 PUFA in Cancers: Structures and Mechanisms
Current Topics in Medicinal Chemistry Prostate Cancer Prevention in the Developing World - What are we Waiting for?
Current Pharmacogenomics and Personalized Medicine Review of the Contribution of Radiolabelled Tracers for Tumour Cell Status Imaging
Current Medical Imaging Drug-Drug Interactions: Antiretroviral Drugs and Recreational Drugs
Recent Patents on CNS Drug Discovery (Discontinued) Human Whey Promotes Sessile Bacterial Growth, Whereas Alternative Sources of Infant Nutrition Promote Planktonic Growth
Current Nutrition & Food Science Selected Approaches for Rational Drug Design and High Throughput Screening to Identify Anti-Cancer Molecules
Anti-Cancer Agents in Medicinal Chemistry Importance of Influx and Efflux Systems and Xenobiotic Metabolizing Enzymes in Intratumoral Disposition of Anticancer Agents
Current Cancer Drug Targets Competitive Interaction Between Plasma Omega-3 Fatty Acids and Arachidonic Acid is Related to Down-Regulation of A Signaling Mediator
Medicinal Chemistry Mechanisms of Intrinsic and Acquired Resistance to EGFR Inhibitors
Current Cancer Therapy Reviews Histone Deacetylases as Targets for Dietary Cancer Preventive Agents: Lessons Learned with Butyrate, Diallyl Disulfide, and Sulforaphane
Current Drug Targets RGD-based Therapy: Principles of Selectivity
Current Pharmaceutical Design Contrast Agents in X-Ray Computed Tomography and Its Applications in Oncology
Anti-Cancer Agents in Medicinal Chemistry Environmental Exposure, and Other Behavioral Risk Factors in Breast Cancer
Current Cancer Therapy Reviews